Literature DB >> 24619111

Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.

Julia K Götzl1, Kohji Mori, Markus Damme, Katrin Fellerer, Sabina Tahirovic, Gernot Kleinberger, Jonathan Janssens, Julie van der Zee, Christina M Lang, Elisabeth Kremmer, Jean-Jacques Martin, Sebastiaan Engelborghs, Hans A Kretzschmar, Thomas Arzberger, Christine Van Broeckhoven, Christian Haass, Anja Capell.   

Abstract

Heterozygous loss-of-function mutations in the progranulin (GRN) gene and the resulting reduction of GRN levels is a common genetic cause for frontotemporal lobar degeneration (FTLD) with accumulation of TAR DNA-binding protein (TDP)-43. Recently, it has been shown that a complete GRN deficiency due to a homozygous GRN loss-of-function mutation causes neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disorder. These findings suggest that lysosomal dysfunction may also contribute to some extent to FTLD. Indeed, Grn(-/-) mice recapitulate not only pathobiochemical features of GRN-associated FTLD-TDP (FTLD-TDP/GRN), but also those which are characteristic for NCL and lysosomal impairment. In Grn(-/-) mice the lysosomal proteins cathepsin D (CTSD), LAMP (lysosomal-associated membrane protein) 1 and the NCL storage components saposin D and subunit c of mitochondrial ATP synthase (SCMAS) were all found to be elevated. Moreover, these mice display increased levels of transmembrane protein (TMEM) 106B, a lysosomal protein known as a risk factor for FTLD-TDP pathology. In line with a potential pathological overlap of FTLD and NCL, Ctsd(-/-) mice, a model for NCL, show elevated levels of the FTLD-associated proteins GRN and TMEM106B. In addition, pathologically phosphorylated TDP-43 occurs in Ctsd(-/-) mice to a similar extent as in Grn(-/-) mice. Consistent with these findings, some NCL patients accumulate pathologically phosphorylated TDP-43 within their brains. Based on these observations, we searched for pathological marker proteins, which are characteristic for NCL or lysosomal impairment in brains of FTLD-TDP/GRN patients. Strikingly, saposin D, SCMAS as well as the lysosomal proteins CTSD and LAMP1/2 are all elevated in patients with FTLD-TDP/GRN. Thus, our findings suggest that lysosomal storage disorders and GRN-associated FTLD may share common features.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24619111     DOI: 10.1007/s00401-014-1262-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  99 in total

1.  Progranulin in the hematopoietic compartment protects mice from atherosclerosis.

Authors:  Andrew D Nguyen; Thi A Nguyen; Rajesh K Singh; Delphine Eberlé; Jiasheng Zhang; Jess Porter Abate; Anatalia Robles; Suneil Koliwad; Eric J Huang; Frederick R Maxfield; Tobias C Walther; Robert V Farese
Journal:  Atherosclerosis       Date:  2018-08-30       Impact factor: 5.162

2.  Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.

Authors:  Hideyuki Takahashi; Zoe A Klein; Sarah M Bhagat; Adam C Kaufman; Mikhail A Kostylev; Tsuneya Ikezu; Stephen M Strittmatter
Journal:  Acta Neuropathol       Date:  2017-01-09       Impact factor: 17.088

3.  Proteomic and functional analyses in disease models reveal CLN5 protein involvement in mitochondrial dysfunction.

Authors:  Stefano Doccini; Federica Morani; Claudia Nesti; Francesco Pezzini; Giulio Calza; Rabah Soliymani; Giovanni Signore; Silvia Rocchiccioli; Katja M Kanninen; Mikko T Huuskonen; Marc H Baumann; Alessandro Simonati; Maciej M Lalowski; Filippo M Santorelli
Journal:  Cell Death Discov       Date:  2020-03-30

4.  Regulation of cathepsin D activity by the FTLD protein progranulin.

Authors:  Xiaolai Zhou; Daniel H Paushter; Tuancheng Feng; Cara M Pardon; Christina S Mendoza; Fenghua Hu
Journal:  Acta Neuropathol       Date:  2017-05-10       Impact factor: 17.088

5.  Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway.

Authors:  Lisa P Elia; Amanda R Mason; Amela Alijagic; Steven Finkbeiner
Journal:  J Neurosci       Date:  2019-01-29       Impact factor: 6.167

6.  Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.

Authors:  Zoe A Klein; Hideyuki Takahashi; Mengxiao Ma; Massimiliano Stagi; Melissa Zhou; TuKiet T Lam; Stephen M Strittmatter
Journal:  Neuron       Date:  2017-07-19       Impact factor: 17.173

Review 7.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 8.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

9.  The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.

Authors:  Hiroaki Suzuki; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

Review 10.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.